Filing Details

Accession Number:
0001070081-19-000041
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-07-02 18:46:21
Reporting Period:
2019-06-28
Accepted Time:
2019-07-02 18:46:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1070081 Ptc Therapeutics Inc. PTCT Pharmaceutical Preparations (2834) 043416587
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1578852 Elliott Mark Boulding C/O Ptc Therapeutics, Inc.
100 Corporate Court
South Plainfield NJ 07080
Exec. Vp And Clo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-06-28 7,533 $10.85 37,057 No 4 M Direct
Common Stock Disposition 2019-06-28 7,533 $45.00 29,524 No 4 S Direct
Common Stock Acquisiton 2019-06-28 44,090 $10.85 73,614 No 4 M Direct
Common Stock Disposition 2019-06-28 44,090 $45.00 29,524 No 4 S Direct
Common Stock Acquisiton 2019-06-28 1,844 $27.05 31,368 No 4 M Direct
Common Stock Disposition 2019-06-28 1,844 $45.00 29,524 No 4 S Direct
Common Stock Acquisiton 2019-06-28 22,968 $11.23 52,492 No 4 M Direct
Common Stock Disposition 2019-06-28 22,968 $45.00 29,524 No 4 S Direct
Common Stock Acquisiton 2019-06-28 1,140 $11.23 30,664 No 4 M Direct
Common Stock Disposition 2019-06-28 1,140 $45.00 29,524 No 4 S Direct
Common Stock Acquisiton 2019-07-01 5,910 $10.85 35,434 No 4 M Direct
Common Stock Disposition 2019-07-01 5,910 $45.00 29,524 No 4 S Direct
Common Stock Acquisiton 2019-07-01 384 $10.85 29,908 No 4 M Direct
Common Stock Disposition 2019-07-01 384 $45.00 29,524 No 4 S Direct
Common Stock Acquisiton 2019-07-01 7,307 $27.05 36,831 No 4 M Direct
Common Stock Disposition 2019-07-01 7,307 $45.00 29,524 No 4 S Direct
Common Stock Acquisiton 2019-07-01 70,849 $27.05 100,373 No 4 M Direct
Common Stock Disposition 2019-07-01 70,849 $45.00 29,524 No 4 S Direct
Common Stock Acquisiton 2019-07-01 2,142 $11.23 31,666 No 4 M Direct
Common Stock Disposition 2019-07-01 2,142 $45.00 29,524 No 4 S Direct
Common Stock Acquisiton 2019-07-01 17,500 $18.01 47,024 No 4 M Direct
Common Stock Disposition 2019-07-01 17,500 $45.00 29,524 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right To Buy) Disposition 2019-06-28 7,533 $10.85 7,533 $10.85
Common Stock Stock Option (Right To Buy) Disposition 2019-06-28 44,090 $10.85 44,090 $10.85
Common Stock Stock Option (Right To Buy) Disposition 2019-06-28 1,844 $27.05 1,844 $27.05
Common Stock Stock Option (Right To Buy) Disposition 2019-06-28 22,968 $11.23 22,968 $11.23
Common Stock Stock Option (Right To Buy) Disposition 2019-06-28 1,140 $11.23 1,140 $11.23
Common Stock Stock Option (Right To Buy) Disposition 2019-07-01 5,910 $0.00 5,910 $10.85
Common Stock Stock Option (Right To Buy) Disposition 2019-07-01 384 $0.00 384 $10.85
Common Stock Stock Option (Right To Buy) Disposition 2019-07-01 7,307 $27.05 7,307 $27.05
Common Stock Stock Option (Right To Buy) Disposition 2019-07-01 70,849 $0.00 70,849 $27.05
Common Stock Stock Option (Right To Buy) Disposition 2019-07-01 2,142 $11.23 2,142 $11.23
Common Stock Stock Option (Right To Buy) Disposition 2019-07-01 17,500 $18.01 17,500 $18.01
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
384 2023-05-15 No 4 M Direct
5,910 2023-05-15 No 4 M Direct
78,156 2024-01-28 No 4 M Direct
29,532 2027-01-02 No 4 M Direct
28,392 2027-01-02 No 4 M Direct
0 2023-05-15 No 4 M Direct
0 2023-05-15 No 4 M Direct
70,849 2024-01-28 No 4 M Direct
0 2024-01-28 No 4 M Direct
26,250 2027-01-02 No 4 M Direct
52,500 2028-01-02 No 4 M Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (Right To Buy) $1,149.60 2020-02-02 200 200 Direct
Common Stock Stock Option (Right To Buy) $490.80 2021-04-27 233 233 Direct
Common Stock Stock Option (Right To Buy) $218.40 2022-01-10 191 191 Direct
Common Stock Stock Option (Right To Buy) $51.00 2025-01-02 85,600 85,600 Direct
Common Stock Stock Option (Right To Buy) $30.86 2026-01-03 70,000 70,000 Direct
Common Stock Stock Option (Right To Buy) $33.02 2029-01-21 72,500 72,500 Direct
Common Stock Stock Option (Right To Buy) $33.02 2029-01-21 17,500 17,500 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2020-02-02 200 200 Direct
2021-04-27 233 233 Direct
2022-01-10 191 191 Direct
2025-01-02 85,600 85,600 Direct
2026-01-03 70,000 70,000 Direct
2029-01-21 72,500 72,500 Direct
2029-01-21 17,500 17,500 Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 7, 2018.
  2. Includes 1,112 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2017, 663 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2018 and 715 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2018.
  3. Currently exercisable.
  4. This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018.
  5. This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019.
  6. This option was granted on January 4, 2016, and vests over four years, with 25% of the shares underlying the option vesting on January 4, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 4, 2017.
  7. This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020.
  8. This option was granted on January 22, 2019 and vests over four years, with 50% of the shares underlying the option vesting on January 22, 2022, and the remaining 50% of the original number of shares underlying the option vesting on January 22, 2023.